Albemarle (ALB) Cash & Equivalents (2009 - 2026)

Albemarle's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• Quarterly Cash & Equivalents fell 28.23% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 28.23% YoY) and the FY2025 annual result came in at $1.6 billion, up 35.71% from the prior year.
• Cash & Equivalents was $1.1 billion for Q1 2026 at Albemarle, down from $1.6 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.1 billion in Q1 2024 and bottomed at $463.3 million in Q1 2022.
• A 5-year average of $1.5 billion and a median of $1.6 billion in 2023 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 242.47% in 2023, while the deepest fall reached 40.64% in 2023.
• Albemarle's Cash & Equivalents stood at $1.5 billion in 2022, then sank by 40.64% to $889.9 million in 2023, then surged by 33.97% to $1.2 billion in 2024, then jumped by 35.71% to $1.6 billion in 2025, then plunged by 32.64% to $1.1 billion in 2026.
• Business Quant data shows ALB's Cash & Equivalents at $1.1 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.9 billion in Q3 2025.